サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/09/19 | 1,417 | 1,443 | 1,406 | 1,436 | +20 | +1.4% | 217,000 |
| 2017/09/15 | 1,394 | 1,422 | 1,394 | 1,416 | +11 | +0.8% | 116,900 |
| 2017/09/14 | 1,404 | 1,405 | 1,373 | 1,405 | -1 | -0.1% | 111,000 |
| 2017/09/13 | 1,382 | 1,433 | 1,359 | 1,406 | -1 | -0.1% | 286,000 |
| 2017/09/12 | 1,365 | 1,409 | 1,349 | 1,407 | +59 | +4.4% | 228,100 |
| 2017/09/11 | 1,375 | 1,379 | 1,347 | 1,348 | +56 | +4.3% | 220,700 |
| 2017/09/08 | 1,300 | 1,313 | 1,289 | 1,292 | -1 | -0.1% | 235,700 |
| 2017/09/07 | 1,320 | 1,327 | 1,293 | 1,293 | -27 | -2% | 209,500 |
| 2017/09/06 | 1,300 | 1,345 | 1,289 | 1,320 | -15 | -1.1% | 297,500 |
| 2017/09/05 | 1,402 | 1,415 | 1,335 | 1,335 | -84 | -5.9% | 311,000 |
| 2017/09/04 | 1,436 | 1,440 | 1,395 | 1,419 | -33 | -2.3% | 190,500 |
| 2017/09/01 | 1,470 | 1,474 | 1,440 | 1,452 | -21 | -1.4% | 135,800 |
| 2017/08/31 | 1,453 | 1,473 | 1,453 | 1,473 | +14 | +1% | 117,600 |
| 2017/08/30 | 1,433 | 1,459 | 1,428 | 1,459 | +40 | +2.8% | 168,900 |
| 2017/08/29 | 1,423 | 1,433 | 1,414 | 1,419 | -16 | -1.1% | 88,900 |
| 2017/08/28 | 1,406 | 1,438 | 1,406 | 1,435 | +31 | +2.2% | 153,600 |
| 2017/08/25 | 1,408 | 1,409 | 1,397 | 1,404 | +8 | +0.6% | 51,100 |
| 2017/08/24 | 1,391 | 1,405 | 1,376 | 1,396 | +6 | +0.4% | 81,800 |
| 2017/08/23 | 1,379 | 1,401 | 1,379 | 1,390 | +11 | +0.8% | 136,200 |
| 2017/08/22 | 1,375 | 1,387 | 1,362 | 1,379 | +19 | +1.4% | 81,600 |
| 2017/08/21 | 1,400 | 1,412 | 1,351 | 1,360 | -43 | -3.1% | 211,300 |
| 2017/08/18 | 1,390 | 1,410 | 1,389 | 1,403 | -26 | -1.8% | 124,300 |
| 2017/08/17 | 1,408 | 1,444 | 1,401 | 1,429 | +19 | +1.3% | 117,300 |
| 2017/08/16 | 1,385 | 1,423 | 1,379 | 1,410 | +27 | +2% | 104,900 |
| 2017/08/15 | 1,360 | 1,386 | 1,360 | 1,383 | +34 | +2.5% | 85,200 |
| 2017/08/14 | 1,350 | 1,364 | 1,332 | 1,349 | -30 | -2.2% | 146,700 |
| 2017/08/10 | 1,411 | 1,411 | 1,371 | 1,379 | -36 | -2.5% | 103,000 |
| 2017/08/09 | 1,418 | 1,420 | 1,370 | 1,415 | -7 | -0.5% | 222,000 |
| 2017/08/08 | 1,435 | 1,440 | 1,419 | 1,422 | -12 | -0.8% | 121,200 |
| 2017/08/07 | 1,433 | 1,449 | 1,426 | 1,434 | +29 | +2.1% | 189,000 |
| 2017/08/04 | 1,365 | 1,416 | 1,360 | 1,405 | +18 | +1.3% | 128,200 |
| 2017/08/03 | 1,403 | 1,416 | 1,382 | 1,387 | -29 | -2% | 163,500 |
| 2017/08/02 | 1,400 | 1,425 | 1,400 | 1,416 | +14 | +1% | 100,300 |
| 2017/08/01 | 1,448 | 1,448 | 1,398 | 1,402 | -46 | -3.2% | 247,900 |
| 2017/07/31 | 1,448 | 1,454 | 1,416 | 1,448 | -27 | -1.8% | 176,100 |
| 2017/07/28 | 1,494 | 1,495 | 1,460 | 1,475 | -22 | -1.5% | 159,200 |
| 2017/07/27 | 1,510 | 1,510 | 1,485 | 1,497 | -4 | -0.3% | 104,200 |
| 2017/07/26 | 1,495 | 1,515 | 1,472 | 1,501 | +11 | +0.7% | 125,300 |
| 2017/07/25 | 1,505 | 1,514 | 1,486 | 1,490 | -18 | -1.2% | 139,000 |
| 2017/07/24 | 1,511 | 1,528 | 1,505 | 1,508 | -18 | -1.2% | 89,100 |
| 2017/07/21 | 1,520 | 1,537 | 1,510 | 1,526 | ±0 | ±0% | 113,100 |
| 2017/07/20 | 1,540 | 1,543 | 1,520 | 1,526 | -18 | -1.2% | 143,200 |
| 2017/07/19 | 1,530 | 1,546 | 1,511 | 1,544 | +18 | +1.2% | 265,000 |
| 2017/07/18 | 1,492 | 1,527 | 1,477 | 1,526 | +48 | +3.2% | 309,200 |
| 2017/07/14 | 1,460 | 1,479 | 1,454 | 1,478 | +22 | +1.5% | 125,800 |
| 2017/07/13 | 1,458 | 1,488 | 1,452 | 1,456 | +8 | +0.6% | 147,300 |
| 2017/07/12 | 1,451 | 1,462 | 1,443 | 1,448 | -4 | -0.3% | 102,800 |
| 2017/07/11 | 1,445 | 1,476 | 1,440 | 1,452 | +7 | +0.5% | 189,900 |
| 2017/07/10 | 1,489 | 1,490 | 1,444 | 1,445 | -14 | -1% | 194,300 |
| 2017/07/07 | 1,490 | 1,496 | 1,440 | 1,459 | -50 | -3.3% | 451,900 |
1851～
1900
件表示中 / 2451件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 230,100円 | - | - | 0.00% | - | 106.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 407,100円 | +30.5% | +111.0% | 4.67% | 11.47倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 375,500円 | +14.5% | -2.3% | 2.40% | 13.73倍 | 0.73倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 東和薬品 | 253,400円 | +15.0% | -7.3% | 2.76% | 8.31倍 | 0.79倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 鳥居薬 | 450,500円 | +7.1% | -35.0% | 2.66% | 37.25倍 | 1.04倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム
